Subscribe to our Newsletters !!
In molecular biology, the LAMP (Loop-Mediated Isot
Pharmaceutical laboratories have been adopting imm
Generally, a debate about Isopure protein and regu
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
In a world constantly in motion, Microbioz India r
HiGenoMB® – HiMedia Laboratories committed to combating spread of COVID-19 is thrilled to announce that the Central Drugs Standard Control Organization (CDSCO) has granted approval for two more important COVID Testing products that also recently got the CE-IVD approval.
This extraction free method assesses dry swab samples and supports direct Real time PCR post sample collection. This is an ideal solution to encourage smaller laboratories that cannot afford high end automation and reduces on dependency on skilled technicians to venture into molecular diagnostics.
This three gene multiplex PCR kit can detect two target COVID genes, viz. (N) gene and RNA-dependent RNA polymerase (RdRp) gene along with an internal process control with maximum sensitivity. It is an alternative to our CDSCO approved 4 gene Hi-PCR® Coronavirus (COVID-19) Probe PCR Kit (MBPCR243).
Also read:HiGenoMB®-HiMedia Receives CE-IVD Approval for Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262)
The world needs advanced solutions that improve testing quality and sustain bulk testing with less processing time. Receiving such approvals in time is not only a sign of the excellent product quality but also indicates the innovative mindset to introduce such unique concepts at the right time.
HiMedia has played a pivotal role in the global response against COVID-19. Says Dr. Kavita Khadke, an expert pathologist and Director of Molecular Biology at HiMedia, “We are working on variations in our products so as to keep the public health officials and laboratories one step ahead of the virus, and these tests play a key role, alongside our full menu of diagnostic solutions, in supporting that effort.”
Please visit our website www.himedialabs.com for more details about HiGenoMB® products related COVID Molecular testing.
HiMedia is one of the largest Indian Biosciences company, providing solutions to over 150 countries worldwide with an all-inclusive product range catering to Microbiology, Molecular Biology, Animal Cell culture, Plant Tissue culture, Bio chemicals, Laboratory Aids, Molecular Diagnostic instruments and more. HiGenoMB® encompasses the Molecular Biology Product Range of HiMedia Laboratories Pvt. Ltd. Comprising of DNA/RNA Extraction kits, PCR reagents, NASBA (Nucleic Acid Sequence Based Amplification tests), Proteomics, Molecular biology grade chemicals and buffers and Instrumentation for Research & Diagnostics. Covering major aspects of the most dynamic branches of the Life Sciences group, HiGenoMB® team strives hard to make molecular work enjoyable with its user friendly product range.
